Progress in the Development of Bestatin Analogues as Aminopeptidases Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|18|7|964-976

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.7, 2011-03, pp. : 964-976

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent progress in the development of docetaxel and paclitaxel analogues

By Dubois Joëlle  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 11, 2006-11 ,pp. : 1481-1496

Informa Healthcare

Access to resources Recommend Favorite

Progress in the Development of Matrix Metalloproteinase Inhibitors

By  

Current Medicinal Chemistry, Vol. 15, Iss. 14, 2008-06 ,pp. : 1388-1395

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in the Development of Inhibitors of SH2 Domains

By  

Current Pharmaceutical Design, Vol. 6, Iss. 1, 2000-01 ,pp. : 59-98

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in the Development of Selective Inhibitors of Aurora Kinases

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 2, 2005-04 ,pp. : 199-213

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in the Development of Selective Inhibitors of Aurora Kinases

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 8, 2005-08 ,pp. : 807-821

Bentham Science Publishers

Access to resources Recommend Favorite